AFIAS total solutions for the diagnosis of COVID-19
Sars-Cov-2 (COVID-19), the newly identified coronavirus 2019-nCOV, causes pneumonia so that prevention and control of the infection has become highly required. Avant-Medical partnered with Boditech to provide the Netherlands, Belgium and Luxembourg with their AFIAS COVID-19 Solutions. Consisting of antigen & antibody kits, optimized for fast on-site diagnosis with high accuracy and a new Interleukin-6 test for the identification of confirmed COVID-19 patients who could be at high risk.
AFIAS COVID-19 Antigen Test
AFIAS COVID-19 Antibody Test
AFIAS Interleukin-6 Test
So far, tens of millions have been infected and the following huge economic impact shakes global medical and social fundamentals. Since symptoms become rapidly severe without a proper treatment after onset of illness, early diagnosis of the virus infection is quite crucial. Boditech Med Inc. is a leader in in-vitro diagnostic area and provides total solution of COVID-19 diagnosis that can be used in any environment.
Product selection guide for the diagnosis of COVID-19 infection
Boditech COVID-19 Product List:
The AFIAS-1 measures the concentration of a targeted analyte in a sample, using quantitative or semi-quantitative methods using blood, urine, and other samples. The AFIAS-1 reader is easy to carry and has a simple structure. Also, AFIAS-1 uses all-in-one cartridges which automates the entire procedures from sample preparation to test when user loads sample only.
The AFIAS-6 uses blood, urine, and other samples to measure quantitatively or semi-quantitatively the concentration of targeted analyte. AFIAS all-in-one cartridges are designed to optimize the structure and operating principle of the reader. Its automated test process enables to carry out multiple simultaneous tests for six different samples.
We are working with different brands to offer you a broad variation of products. Do you want to know more about our brands?